CoChat

The oral microbiome of early stage Parkinson’s disease and its relationship with functional measures of motor and non-motor function

Open access

The DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index.

Abstract

Changes in the function and microbiome of the upper and lower gastrointestinal tract have been documented in Parkinson's disease (PD), although most studies have examined merely fecal microbiome profiles and patients with advanced disease states. In the present study we sought to identify sensitive and specific biomarkers of changes in the oral microbiome of early stage PD through shotgun metatranscriptomic profiling. We recruited 48 PD subjects and 36 age- and gender-matched healthy controls. Subjects completed detailed assessments of motor, cognitive, balance, autonomic and chemosensory (smell and taste) functions to determine their disease stage. We also obtained a saliva sample for profiling of microbial RNA and host mRNA using next generation sequencing. We found no differences in overall alpha and beta diversity between subject groups. However, changes in specific microbial taxa were observed, including primarily bacteria, but also yeast and phage. Nearly half of our findings were consistent with prior studies in the field obtained through profiling of fecal samples, with others representing highly novel candidates for detection of early stage PD. Testing of the diagnostic utility of the microbiome data revealed potentially robust performance with as few as 11 taxonomic features achieving a cross-validated area under the ROC curve of 0.90 and overall accuracy of 84.5%. Bioinformatic analysis of 167 different metabolic pathways supported shifts in a small set of distinct pathways involved in amino acid and energy metabolism among the organisms comprising the oral microbiome. In parallel with the microbial analysis, we also examined the evidence for changes in human salivary mRNAs in the same subjects. This revealed significant changes in a set of 9 host mRNAs, several of which mapped to various brain functions and showed correlations with some of the significantly changed microbial taxa. Unexpectedly, we also observed robust correlations between many of the microbiota and functional measures, including those reflecting cognition, balance, and disease duration. These results suggest that the oral microbiome may represent a highly-accessible and informative microenvironment that offers new insights in the pathophysiology of early stage PD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0218252

Cites

76 of 76 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig 1 No differences in family, genus or species biodiversity measures in early stage PD. Whisker box plots indicate mean and range of Shannon alpha diversity (upper) and Bray-Curtis dissimilarity measures (lower) for the family, genus, and species levels of classification.
Fig 1 No differences in family, genus or species biodiversity measures in early stage PD. Whisker box plots indicate mean and range of Shannon alpha diversity (upper) and Bray-Curtis dissimilarity measures (lower) for the family, genus, and species levels of classification.CC BY · PubMed Central
Fig 2 ROC curve performance using the oral microbiome. Empirical ROC performance during cross-validation and its 95th percentile confidence interval are shown. Overall accuracy was 84.5%.
Fig 2 ROC curve performance using the oral microbiome. Empirical ROC performance during cross-validation and its 95th percentile confidence interval are shown. Overall accuracy was 84.5%.CC BY · PubMed Central
Fig 3 Metabolic pathway changes in oral microbiome of early stage PD. Only 6 of the 167 KEGG pathways were changed when examining transcripts from the oral microbiome in PD subjects compared with controls.
Fig 3 Metabolic pathway changes in oral microbiome of early stage PD. Only 6 of the 167 KEGG pathways were changed when examining transcripts from the oral microbiome in PD subjects compared with controls.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 more claim about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 94

Metadata

Authors
Mihaila, D., Donegan, J., Barns, S., LaRocca, D., Du, Q., Zheng, D., Vidal, M., Neville, C., Uhlig, R., & Middleton, F. A.
Affiliations
  • SUNY Upstate Medical University (US)
  • Quadrant Biosciences (United States) (US)
Corresponding author
Middleton, Frank A.
Venue
PLOS ONE
Published
2019-06-27
Volume
14
Issue
6
Pages
e0218252
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2953419696
Cited by
94
References
76
Citations by year
2026: 9 · 2025: 10 · 2024: 11 · 2023: 17 · 2022: 20 · 2021: 13 · 2020: 12 · 2019: 2
FWCI
13.49
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Figshare (submittedVersion, cc-by)
Funders
Quadrant Biosciences
Topics
  • Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
  • Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
Keywords
Parkinson's disease, oral microbiota, early-stage Parkinson's disease, saliva, microbial RNA, biomarkers, diagnostic biomarkers, metatranscriptomics, microbial metabolic pathways, amino acid metabolism, energy metabolism, motor function, non-motor functions, cognition, balance, autonomic function, chemosensory function, disease duration
MeSH terms
Aged, Bacteria, Cognition, Female, Humans, Male, Motor Activity, Mouth, Parkinson Disease, Phylogeny, Reaction Time, RNA, Messenger, ROC Curve, Saliva, Biodiversity, Gene Regulatory Networks, Metabolic Networks and Pathways, Microbiota

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.